Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents
Nicole R. Florance(Children's Hospital of Philadelphia), Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Amy J. Gleichman(The Ohio State University), Myrna R. Rosenfeld(University of Pennsylvania), Saba Ahmad(Children's Hospital of Philadelphia), Christopher Wai Kei Lam(University of Nevada, Las Vegas), Nadja G. Peter(Children's Hospital of Philadelphia), Christina L. Szperka(Children's Hospital of Philadelphia), Heather E. Moss(University of Pennsylvania), Lei Zhou(Tianjin University of Traditional Chinese Medicine), Rebecca Davis(University of Pennsylvania), David R. Lynch(Children's Hospital of Philadelphia), Carol Glaser(California Health and Human Services Agency), Cynthia Campen(Children's Hospital of Philadelphia)
Cited by 1,097
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k